Pros & Cons of B2C Marketing in Pharma

The short version

Consumer brands know how to make people feel something in six seconds. Patient-facing campaigns benefit most from borrowing that instinct.
A cardiologist isn’t choosing between two sneaker brands. She's deciding whether a mechanism of action holds up for the patient in front of her.
The useful part of B2C isn’t the tone, it's the respect for the viewer's time. A physician who has little of it won’t open a twelve-page follow-up just because it exists.

Pharma is borrowing consumer marketing's playbook, but the physician in the room changes the math. Here's what we found, and what it means for how you build your next story.

01Why the B2C instinct makes sense

Consumer brands know how to make people feel something in six seconds. Patient-facing campaigns benefit the most from borrowing that instinct, story and clarity over a data table.

Same finding, two shapesStatic page

The publication as published

The same finding, designed

One finding

Pros & Cons of B2C Marketing in Pharma, told as a story a physician can finish.

The physician readerstill scanning the table…

0:38time to the point

Fig. 01The same approved finding, shown as a static page and as a designed story.

02Where the model breaks

A cardiologist isn’t choosing between two sneaker brands. She's deciding whether a mechanism of action holds up for the patient in front of her. A pharma claim has to trace back to an approved source, every time.

“The useful part of B2C isn't the tone, it's the respect for the viewer's time.”

03What actually transfers

The useful part of B2C isn’t the tone, it's the respect for the viewer's time. A physician who has 63% of the time to read only the abstract of your publication is not going to open a twelve-page follow-up because it exists.

04The honest answer

Borrow the attention-getting instincts. Keep the evidence-first backbone. The physicians reading your science were never the same audience as consumer shoppers.

Consumer marketing earns the view. Engage gives the viewer somewhere to go with it.

The B2C playbook stops when the video ends. And in pharma the viewer you actually need is the physician, not a consumer. PubVisual Engage builds moments into the approved story where her interest becomes an approved next step: a question asked, a paper requested, time booked. Tap a face and see where each physician acts.

Frequently asked questions

Borrow the attention-getting instincts, keep the evidence-first backbone. A cardiologist isn't choosing between two sneaker brands. She's deciding whether a mechanism of action holds up for the patient in front of her.

The respect for the viewer's time, not the tone. A physician with little of it won't open a twelve-page follow-up just because it exists.

At the evidence. A pharma claim has to trace back to an approved source, every time, and the physicians reading your science were never the same audience as consumer shoppers.